Table 4.
Ensuring survival of transplanted cells |
---|
• Autologous or Syngeneic transplant |
• Transplant in utero |
• Transplant to an immune privileged site |
• Co-transplant of immune modulatory cells |
• Localized immunesuppression (Indoleamine, NO, HLA-G) |
• CTL blockade, anti-TCR therapy |
• ABO tolerization and other antigen tolerization |
• T-regs- (CD24-) to induce tolerization |
• Mixed chimerism with accompanied bone marrow transplant |
• iPSC engineering |
• Generation of DC cells |
• Thymic rejuvenation |
• HLA matching with immune suppression |